Ortin Global Limited (ORTINGLOBE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ortin Global Limited (ORTINGLOBE) has a cash flow conversion efficiency ratio of -0.597x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-7.75 Million ≈ $-83.86K USD) by net assets (Rs13.00 Million ≈ $140.55K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Ortin Global Limited worth for the company's overall valuation and market capitalisation.
Ortin Global Limited - Cash Flow Conversion Efficiency Trend (2021–2026)
This chart illustrates how Ortin Global Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Ortin Global Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ortin Global Limited ranked by their cash flow conversion efficiency. Explore ORTINGLOBE cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kingman Minerals Ltd
V:KGS
|
-0.113x |
|
Appili Therapeutics Inc
TO:APLI
|
0.018x |
|
Severfield PLC
LSE:SFR
|
-0.027x |
|
Nusantara Inti Corpora Tbk
JK:UNIT
|
-0.084x |
|
Rights and Issues Investment Trust Public Limited Company
LSE:RIII
|
0.009x |
|
Shyam Telecom Limited
NSE:SHYAMTEL
|
0.000x |
|
GGX Gold Corp
V:GGX
|
0.054x |
|
Bank Pembangunan Daerah Banten Tbk PT
JK:BEKS
|
0.265x |
Annual Cash Flow Conversion Efficiency for Ortin Global Limited (2021–2026)
The table below shows the annual cash flow conversion efficiency of Ortin Global Limited from 2021 to 2026. View ORTINGLOBE stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs12.37 Million ≈ $133.79K |
Rs-5.62 Million ≈ $-60.76K |
-0.454x | -118.87% |
| 2025-03-31 | Rs19.77 Million ≈ $213.86K |
Rs-4.10 Million ≈ $-44.37K |
-0.207x | +87.76% |
| 2024-03-31 | Rs28.24 Million ≈ $305.39K |
Rs-47.87 Million ≈ $-517.71K |
-1.695x | -7171.33% |
| 2023-03-31 | Rs108.65 Million ≈ $1.17 Million |
Rs-2.53 Million ≈ $-27.39K |
-0.023x | -111.89% |
| 2022-03-31 | Rs109.57 Million ≈ $1.18 Million |
Rs21.48 Million ≈ $232.29K |
0.196x | -87.66% |
| 2021-03-31 | Rs113.56 Million ≈ $1.23 Million |
Rs180.34 Million ≈ $1.95 Million |
1.588x | -- |
About Ortin Global Limited
Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quin… Read more